Literature DB >> 12538736

Molecular cytogenetic aberrations in autosomal dominant polycystic kidney disease tissue.

Jean Gogusev1, Ichiro Murakami, Mireille Doussau, Louise Telvi, Alexandre Stojkoski, Philippe Lesavre, Dominique Droz.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a genetically heterogeneous disorder characterized by focal cyst formation from any part of the nephron. The molecular bases include germinal mutation of either PKD1 or PKD2 genes, enhanced expression of several protooncogenes, alteration of the TGF-alpha/EGF/EGF receptor (EGFR) axis, and disturbed regulation of proliferative/apoptosis pathways. To identify new locations of ADPKD related oncogenes and/or tumor suppressor genes (TSG), comparative genomic hybridization (CGH) and loss of heterozygosity (LOH) analyses were performed for a series of individual cysts (n = 24) from eight polycystic kidneys. By CGH, imbalances were detected predominantly on chromosomes 1p, 9q, 16p, 19, and 22q in all tissues. DNA copy number gain was seen on chromosomes 3q and 4q in five samples. The CGH data were supplemented by LOH analysis using 83 polymorphic microsatellite markers distributed along chromosomes 1, 9, 16, 19, and 22. The highest frequency of LOH was found on the 1p35-36 and 16p13.3 segments in cysts from seven samples. Allelic losses on 9q were detected in six, whereas deletions at 19p13 and 22q11 bands were observed in three polycystic kidneys. These results indicate that the deleted chromosomal regions may contain genes important in ADPKD initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538736     DOI: 10.1097/01.asn.0000046963.60910.63

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

Review 1.  Cilium, centrosome and cell cycle regulation in polycystic kidney disease.

Authors:  Kyung Lee; Lorenzo Battini; G Luca Gusella
Journal:  Biochim Biophys Acta       Date:  2011-03-02

2.  Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Authors:  Edgar S Wills; Wybrich R Cnossen; Joris A Veltman; Rob Woestenenk; Marloes Steehouwer; Jody Salomon; René H M Te Morsche; Meritxell Huch; Jayne Y Hehir-Kwa; Martijn J Banning; Rolph Pfundt; Ronald Roepman; Alexander Hoischen; Joost P H Drenth
Journal:  Eur J Hum Genet       Date:  2016-08-24       Impact factor: 4.246

Review 3.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

4.  Polycystic kidney disease protein fibrocystin localizes to the mitotic spindle and regulates spindle bipolarity.

Authors:  Jingjing Zhang; Maoqing Wu; Shixuan Wang; Jagesh V Shah; Patricia D Wilson; Jing Zhou
Journal:  Hum Mol Genet       Date:  2010-06-16       Impact factor: 6.150

5.  Loss of polycystin-1 causes centrosome amplification and genomic instability.

Authors:  Lorenzo Battini; Salvador Macip; Elena Fedorova; Steven Dikman; Stefan Somlo; Cristina Montagna; G Luca Gusella
Journal:  Hum Mol Genet       Date:  2008-06-19       Impact factor: 6.150

6.  Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3.

Authors:  Rachaneekorn Tammachote; Cynthia J Hommerding; Rachel M Sinders; Caroline A Miller; Peter G Czarnecki; Amanda C Leightner; Jeffrey L Salisbury; Christopher J Ward; Vicente E Torres; Vincent H Gattone; Peter C Harris
Journal:  Hum Mol Genet       Date:  2009-06-10       Impact factor: 6.150

7.  Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrian Y Tan; Tuo Zhang; Alber Michaeel; Jon Blumenfeld; Genyan Liu; Wanying Zhang; Zhengmao Zhang; Yi Zhu; Lior Rennert; Che Martin; Jenny Xiang; Steven P Salvatore; Brian D Robinson; Sandip Kapur; Stephanie Donahue; Warren O Bobb; Hanna Rennert
Journal:  J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 10.121

8.  Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.

Authors:  Sony Prasad; John Patrick McDaid; Frederick Wai Keung Tam; John Lionel Haylor; Albert Chee Meng Ong
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

Review 9.  A polycystin-centric view of cyst formation and disease: the polycystins revisited.

Authors:  Albert C M Ong; Peter C Harris
Journal:  Kidney Int       Date:  2015-07-22       Impact factor: 10.612

10.  Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.

Authors:  Annegien T Kenter; Eveline Rentmeester; Job van Riet; Ruben Boers; Joachim Boers; Mehrnaz Ghazvini; Vanessa J Xavier; Geert J L H van Leenders; Paul C M S Verhagen; Marjan E van Til; Bert Eussen; Monique Losekoot; Annelies de Klein; Dorien J M Peters; Wilfred F J van IJcken; Harmen J G van de Werken; Robert Zietse; Ewout J Hoorn; Gert Jansen; Joost H Gribnau
Journal:  Stem Cells Transl Med       Date:  2020-03-12       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.